Home > Healthcare > Biotechnology > Bioservices > Cell & Gene Therapy Manufacturing Services Market

Cell & Gene Therapy Manufacturing Services Market Size

Report ID: GMI5689
Published Date: May 2023
Report Format: PDF

Download Free Sample

Cell & Gene Therapy Manufacturing Services Market Size

Cell & Gene Therapy Manufacturing Services Market size valued at USD 4.85 billion in 2022 and is predicted to record more than 19.9% CAGR from 2023 and 2032. Factors such as advancements in cell and gene therapy manufacturing technology, regulatory support, and increase in investment and funding, are influencing the market development.

Cell & Gene Therapy Manufacturing Services Market

To get key market trends

Download Free Sample

The rising prevalence of chronic and genetic diseases such as cancer, rare genetic disorders, and autoimmune diseases, is increase the demand for cell and gene therapies. These therapies have the potential to offer curative or long-term treatment options for these conditions which are often difficult to treat using traditional therapies. These factors are fuelling the expansion of the cell & gene therapy manufacturing services industry.

Cell & Gene Therapy Manufacturing Services Market Report Attributes
Report Attribute	Details
Base Year:	2022
Cell & Gene Therapy Manufacturing Services Market Size in 2022:	USD 4.85 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	19.9%
2032 Value Projection:	USD 29.57 Billion
Historical Data for:	2018 to 2022
No. of Pages:	230
Tables, Charts & Figures:	483
Segments covered:	Type, Mode, Indication, End-user, and Region
Growth Drivers:	Increasing prevalence of cancer and other diseases Increasing grants and investments for development of cell and gene therapies Increasing pharmaceutical R&D spending Technological advancements in cell & gene therapy technologies
Pitfalls & Challenges:	High risk of mutagenesis Lack of standardized production systems for cell and gene therapy products

Learn more about the key segments shaping this market

Download Free Sample

The development of advanced therapeutics has been crucial in altering the treatment paradigm for a wide range of life-threatening and rare diseases, as well as in reshaping the biopharmaceutical market. Increasing advance technology, such as gene editing tools and next-generation sequencing, are propelling innovation in the research and manufacture of cell and gene treatments. These technologies have the potential to increase the therapeutics' safety, effectiveness, and scalability. The rapid development of the advanced therapeutic landscape is a key driver of the cell & gene therapy manufacturing services market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of cell and gene therapy manufacturing services crossed USD 4.8 billion in 2022 and could register over 19.9% CAGR between 2023 and 2032, owing to regulatory support, enhanced manufacturing technology and a surge in investments worldwide.

The cell segment holds the major share of cell and gene therapy manufacturing services industry, with increasing number of clinical trials and the need to provide advanced therapeutic products to a growing consumer base.

The oncology applications is expected to grow at over 20% CAGR during 2023-2032, due to factors such as need for personalized medicine and advancements in genetic engineering.

North America held over 46% share of cell and gene therapy manufacturing services market in 2022 and is growing at a steady pace, with the presence of a large number of CROs, increased spending on R&D and strong regulatory framework.